{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:15:31Z","timestamp":1783156531872,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472157"],"award-info":[{"award-number":["82472157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22405192"],"award-info":[{"award-number":["22405192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"China Pharmaceutical University State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","award":["SKLNMZZ2024JS36"],"award-info":[{"award-number":["SKLNMZZ2024JS36"]}],"id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007166","name":"JIangsu Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101410","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:27:38Z","timestamp":1778084858000},"page":"101410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering biodegradable lipid nanoparticles with endo-lysosomal escape capability for chronological therapeutic immunomodulation to enhance interleukin-15 therapy"],"prefix":"10.1016","volume":"87","author":[{"given":"Rui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wennan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunqun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-0575","authenticated-orcid":false,"given":"Ahu","family":"Arslan-Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-3873","authenticated-orcid":false,"given":"Wenpei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101410_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6515","article-title":"TIPE2 is a checkpoint of natural killer cell maturation and antitumor immunity","volume":"7","author":"Bi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2026.101410_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbagrm.2009.06.005","article-title":"The Toll-like receptor 3:dsRNA signaling complex","volume":"1789","author":"Botos","year":"2009","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.drup.2026.101410_bib3","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3390\/pharmaceutics13122003","article-title":"Immunotherapy for triple-negative breast cancer","volume":"13","author":"Cao","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drup.2026.101410_bib4","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS21-PL2","article-title":"Abstract PL2: triple negative breast cancer - pitfalls and progress","volume":"82","author":"Carey","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101410_bib5","article-title":"Stiffness-gated cytoplasmic mRNA delivery through engineered membrane fusion for breast cancer immunotherapy","volume":"38","author":"Chen","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2026.101410_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.xphs.2023.11.023","article-title":"Factors affecting stability of RNA - temperature, length, concentration, pH, and buffering species","volume":"113","author":"Chheda","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drup.2026.101410_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101410_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc7804","article-title":"Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models","volume":"13","author":"Hotz","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drup.2026.101410_bib9","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1021\/acsnano.3c03195","article-title":"Reactive oxygen species-sensitive biodegradable mesoporous silica nanoparticles harboring TheraVac elicit tumor-specific immunity for colon tumor treatment","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2026.101410_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","article-title":"Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects","volume":"32","author":"Jia","year":"2017","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/j.drup.2026.101410_bib11","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2019-127771","article-title":"NKTR-255, a polymer-conjugated IL-15, enhances antibody-dependent cellular cytotoxicity mediated by NK cells in a B cell lymphoma model","volume":"134","author":"Miyazaki","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101410_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/0008-5472.CAN-12-2660","article-title":"Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein","volume":"73","author":"Ochoa","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101410_bib13","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1073\/pnas.0801003105","article-title":"IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis","volume":"105","author":"Oh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101410_bib14","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","article-title":"Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA","volume":"17","author":"Patel","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.drup.2026.101410_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101410_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cyto.2014.11.018","article-title":"IL12Rbeta1: the cytokine receptor that we used to know","volume":"71","author":"Robinson","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.drup.2026.101410_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2026.101410_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.drup.2026.101410_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2026.101410_bib20","article-title":"Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC","volume":"13","author":"Stravokefalou","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.drup.2026.101410_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.02.021","article-title":"Sonoporation enhances liposome accumulation and penetration in tumors with low EPR","volume":"231","author":"Theek","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.drup.2026.101410_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijpharm.2012.10.047","article-title":"Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT)","volume":"441","author":"Vadlapudi","year":"2013","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.drup.2026.101410_bib23","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","volume":"11","author":"Waggoner","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.drup.2026.101410_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202135","article-title":"Diselenide-based dual-responsive prodrug as pyroptosis inducer potentiates cancer immunotherapy","volume":"12","author":"Wan","year":"2023","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.drup.2026.101410_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jconrel.2024.01.039","article-title":"A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy","volume":"367","author":"Wang","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.drup.2026.101410_bib26","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1038\/s41467-023-42155-z","article-title":"Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101410_bib27","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1021\/jacs.4c00731","article-title":"Controlled in situ self-assembly of biotinylated trans-cyclooctene nanoparticles for orthogonal dual-pretargeted near-infrared fluorescence and magnetic resonance imaging","volume":"146","author":"Weng","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drup.2026.101410_bib28","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1021\/acsnano.3c04507","article-title":"Fluorinated lipid nanoparticles for enhancing mRNA delivery efficiency","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2026.101410_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control Release"},{"key":"10.1016\/j.drup.2026.101410_bib30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41467-018-03779-8","article-title":"The fluorination effect of fluoroamphiphiles in cytosolic protein delivery","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101410_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cac2.12311","article-title":"Crosstalk between IL-15R\u03b1(+) tumor-associated macrophages and breast cancer cells reduces CD8(+) T cell recruitment","volume":"42","author":"Zhang","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.drup.2026.101410_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202415078","article-title":"Plasma membrane targeted photodynamic nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells","volume":"37","author":"Zhong","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2026.101410_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:18:24Z","timestamp":1783153104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":33,"alternative-id":["S1368764626000610"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101410","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering biodegradable lipid nanoparticles with endo-lysosomal escape capability for chronological therapeutic immunomodulation to enhance interleukin-15 therapy","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101410"}}